Today: 20 March 2026
Subscribe
Browse Category

NYSE:TAK 21 August 2025 - 11 October 2025

Protagonist Therapeutics: Small Biotech Skyrockets on Buyout Buzz & Breakthrough Trials

Protagonist Therapeutics: Small Biotech Skyrockets on Buyout Buzz & Breakthrough Trials

Protagonist Therapeutics shares surged over 30% to nearly $89 on October 10, 2025, after reports that Johnson & Johnson is in talks to acquire the company. Trading was briefly halted due to volatility. The company, valued at about $5.4 billion, recently announced positive trial results for its lead drugs and secured major partnerships with J&J and Takeda.
11 October 2025
·····

Stock Market Today

  • Fundstrat's GRNI ETF Hits Unusual Volume Amid Mixed Component Performance
    March 20, 2026, 1:05 PM EDT. The Fundstrat Granny Shots US Large Cap & Income ETF (GRNI) traded over 633,000 shares Friday, far exceeding its three-month average of about 71,000. GRNI shares slipped 0.6% on the day. Major components saw varied activity: Nvidia's stock declined 1.5% on over 90 million shares, Tesla fell 1.1% with volume surpassing 34 million. Oneok led gains, rising 3.7%, while Vistra lagged, down 6.5%. The surge in ETF trading volume highlights increased investor interest amid mixed performance among key holdings.
Go toTop